Literature DB >> 2227593

DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix.

G G Kenter1, C J Cornelisse, E J Aartsen, W Mooy, J Hermans, A P Heintz, G J Fleuren.   

Abstract

Flow cytometry was used to measure DNA content of tumor cells in paraffin-embedded archival material from 89 patients with squamous cell carcinoma of the cervix uteri stages IB and IIA. Patients were all treated with radical hysterectomy and transperitoneal lymphadenectomy. Twenty-four percent received radiotherapy postoperatively because of tumor spread into parametria or positive lymph nodes. Ploidy grade was compared to other prognostic factors. DNA-aneuploidy was seen in 44 (49%), DNA-diploidy in 16 (18%) and 29 (33%) of the tumors were DNA-periploid. Sixty-nine (78%) patients were in FIGO stage IB, 20 (22%) in IIA. In 19 (21%) lymph node metastases were found, vasoinvasion in 25 (28%). Overall disease-specific 5-year survival was 80%. There was a significant effect of positive lymph nodes (90% vs 47%) and vasoinvasion (87% vs 64%) on the 5-year survival (resp. P less than 0.01 and P = 0.02). No correlation was found between stage (81% for IB vs 80% for IIA) or DNA-ploidy grade (81% for aneuploidy, 82% for periploidy, 79% for diploidy) and survival (resp. P = 0.9 and P = 0.8). Ploidy grade was equally divided over other prognostic factors. In stepwise Cox regression analysis DNA-ploidy grade showed no independent effect on survival. We conclude that DNA flow cytometry in this material was of no additional prognostic value.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227593     DOI: 10.1016/0090-8258(90)90429-o

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  DNA cell-cycle analysis of cervical cancer by flow cytometry using simultaneous cytokeratin labelling for identification of tumour cells.

Authors:  R Kimmig; T Kapsner; H Spelsberg; M Untch; H Hepp
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

2.  Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.

Authors:  B S Bolger; T G Cooke; R P Symonds; A B MacLean; P D Stanton
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.